‘Breaking’ patents would harm innovation: think tank
05-03-2019
Olivier Le Moal / Shutterstock.com
A group of more than 100 medical, scientific, patient advocacy and women’s health organisations have opposed a recent proposal to amend section 101 of the US Patent Act.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
US Patent Act, patent eligibility, gene patenting, Senate Judiciary Subcommittee on Intellectual Property, Chris Coons, Thom Tillis
